The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes

Documenti analoghi

• A nationwide 12‐month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe events
  di: Jean‐Pierre Riveline, et al.
  Pubblicazione: (2025)
• Psychosocial outcomes among adults with type 1 diabetes using a tubeless automated insulin delivery system compared with sensor augmented pump therapy: A randomised, parallel‐group clinical trial sub‐study
  di: Jean‐Pierre Riveline, et al.
  Pubblicazione: (2026)
• A retrospective observational study evaluating the safety and effectiveness of commercially available automated insulin delivery systems in people with type 1 diabetes and gastroparesis
  di: Rachael J. L. Tan, et al.
  Pubblicazione: (2026)
• Postprandial time in tight range with faster insulin aspart compared with standard insulin aspart in youth with type 1 diabetes using automated insulin delivery
  di: Klemen Dovč, et al.
  Pubblicazione: (2025)
• Fully automated insulin delivery systems in type 1 diabetes: A systematic review and meta‐analysis
  di: Wenqi Fan, et al.
  Pubblicazione: (2025)